Close this search box.

Target Identification and Portfolio Planning

RNA Advisors supports life sciences and healthcare companies and investors with target identification and portfolio planning. Our team’s experience helps our clients align their internal performance goals against well-supported projections of future outcomes for purposes of making capital allocation decisions. These decisions arise in a range of situations, such as in-licensing assets, investing in or acquiring companies, building product pipelines, and identifying label expansion opportunities for existing biopharmaceutical and biotech therapies.  

Highlighted Case Study

Due Diligence Support (Buy-Side): Fund Manager

Highlighted Case Study

Supporting the Entire Life Cycle: Biotech Company

Highlighted Case Study

Market Assessment: Biopharma Company

What Our Clients Say

Sign Up for Periodic Updates

Enter your email address below to receive updates from RNA Advisors.